MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

Profile

Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.26B
P/E Ratio
101.14
Total Cash
421.68M
Projected Growth
N/A
Total Debt
6.36M
Revenue
741.17M
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash/Share
4.01
Total Debt/Equity
374.71
Revenue/Share
6.19 USD as % of share price

Fundamentals

CORT
Capitalization
9.26B
P/E Ratio
101.14
Risk (Beta)
0.24
Dividend Yield
N/A
Total Cash
422M
Total Cash/Share
4.01
Total Debt
6.36M
Total Debt/Equity
374.71
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.19%
Revenue
741M
ROE
N/A
Book Value
632M
P/B Ratio
14.64
Cash Flow
N/A
Earnings
1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
139K
Current Ratio
3.14
Current Revenue Per Employee
415276.00
Dividends Per Share - Security
N/A
EBITDA
67.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.79
Revenue To Assets
13.02
Shares Held By Institutions
9.33B
Shares Outstanding - Current
105M
Total Liabilities
192M
Total Volume MTD
N/A
Value
-1
Gain YTD
72.911
View a ticker or compare two or three
CORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CORT showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com